Doubling down on genetics-guided drug development, Regeneron to buy 23andMe – FirstWord Pharma

  1. Doubling down on genetics-guided drug development, Regeneron to buy 23andMe  FirstWord Pharma
  2. Genetic data will be safeguarded with 23andMe sale, drugmaker vows  The Washington Post
  3. Regeneron wins bid to buy 23andMe out of bankruptcy  BioPharma Dive

Read the rest here:
Doubling down on genetics-guided drug development, Regeneron to buy 23andMe - FirstWord Pharma

Related Posts